Search

Author/Creator Jacobson, Eric W.

1. A phase II, randomized, placebo‐controlled, double‐blind, multi‐dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes. (July 2014)

Authors:
Baksi, Arun; Kraydashenko, Oleg; Zalevkaya, Alsu; Stets, Roman; Elliott, Peter; Haddad, Jonathan; Hoffmann, Ethan; Vlasuk, George P.; Jacobson, Eric W.
Journal:
British journal of clinical pharmacology
Issue:
Volume 78:Number 1(2014:Jul.)
Page Start:
69
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Cardiovascular Effects of a Novel SIRT1 Activator, SRT2104, in Otherwise Healthy Cigarette Smokers. Issue 3 (14th June 2013)

Authors:
Venkatasubramanian, Sowmya; Noh, Radzi Mohd; Daga, Shruti; Langrish, Jeremy P.; Joshi, Nikhil V.; Mills, Nicholas L.; Hoffmann, Ethan; Jacobson, Eric W.; Vlasuk, George P.; Waterhouse, Brian R.; Lang, Ninian N.; Newby, David E.
Journal:
Journal of the American Heart Association
Issue:
Volume 2:Issue 3(2013:Jun.)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Cardiovascular Effects of a Novel SIRT1 Activator, SRT2104, in Otherwise Healthy Cigarette Smokers. Issue 3 (June 2013)

Authors:
Venkatasubramanian, Sowmya; Noh, Radzi Mohd; Daga, Shruti; Langrish, Jeremy P.; Joshi, Nikhil V.; Mills, Nicholas L.; Hoffmann, Ethan; Jacobson, Eric W.; Vlasuk, George P.; Waterhouse, Brian R.; Lang, Ninian N.; Newby, David E.
Journal:
Journal of the American Heart Association
Issue:
Volume 2:Issue 3(2013:Jun.)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗